KKR to acquire up to 63% ownership stake in GenesisCare

GenesisCare and Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, "KKR") announced that agreements have been entered into under which KKR will acquire up to a 63% ownership stake in GenesisCare, subject to shareholder acceptance.

GenesisCare operates an Australia-wide network of comprehensive cancer and cardiovascular care centres. The company is a leader in cancer and cardiovascular service provision and is committed to improving clinical outcomes and access for patients.

Comprising a team of doctors, healthcare specialists and management professionals, GenesisCare embraces a collegiate and innovative spirit that encourages advancements in patient care. The organization has more than 1,000 employees that have helped provide more than 350,000 patient treatments across Australia in the past 12 months.

"KKR acknowledges the essential role played by GenesisCare in providing the healthcare outcomes to patients in communities right around Australia," Mr. Justin Reizes, Head of KKR Australia said.

"We look forward to supporting GenesisCare as it seeks to expand services further into areas of unmet need."

Mr. Dan Collins, Managing Director of GenesisCare said KKR would bring proven global resources and deep healthcare expertise needed to meet the challenges confronting Australia's healthcare system.

"Our commitment to meet the needs of our patients continues, as does our plans to innovate how care is delivered.

"Our talented doctors and supporting teams of medical professionals have combined to build a great organization. We make a positive impact wherever we have a presence. Together with KKR, GenesisCare can now continue to lead care and access standards and improve the patient experience," Mr. Collins said.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI model offers hope for detecting brain cancer spread without surgery